Gotowa bibliografia na temat „Autoimmune diseases”

Utwórz poprawne odniesienie w stylach APA, MLA, Chicago, Harvard i wielu innych

Wybierz rodzaj źródła:

Zobacz listy aktualnych artykułów, książek, rozpraw, streszczeń i innych źródeł naukowych na temat „Autoimmune diseases”.

Przycisk „Dodaj do bibliografii” jest dostępny obok każdej pracy w bibliografii. Użyj go – a my automatycznie utworzymy odniesienie bibliograficzne do wybranej pracy w stylu cytowania, którego potrzebujesz: APA, MLA, Harvard, Chicago, Vancouver itp.

Możesz również pobrać pełny tekst publikacji naukowej w formacie „.pdf” i przeczytać adnotację do pracy online, jeśli odpowiednie parametry są dostępne w metadanych.

Artykuły w czasopismach na temat "Autoimmune diseases"

1

Davidson, Anne, i Betty Diamond. "Autoimmune Diseases". New England Journal of Medicine 345, nr 5 (2.08.2001): 340–50. http://dx.doi.org/10.1056/nejm200108023450506.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
2

WOOTTON, JACQUELINE C. "Autoimmune Diseases". Journal of Women's Health & Gender-Based Medicine 8, nr 5 (czerwiec 1999): 689–91. http://dx.doi.org/10.1089/jwh.1.1999.8.689.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
3

Pego-Reigosa, Jose Maria, i David A. Isenberg. "Autoimmune diseases". Medicine 36, nr 5 (maj 2008): 279–83. http://dx.doi.org/10.1016/j.mpmed.2008.03.013.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
4

Kalden, J. R., i M. Herrmann. "Autoimmune Diseases in Humans, e.g. Autoimmune Rheumatic Diseases". Intervirology 35, nr 1-4 (1993): 176–85. http://dx.doi.org/10.1159/000150308.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
5

Lohse, Ansgar W. "Autoimmune Lebererkrankungen. Autoimmune liver diseases". Laboratoriums Medizin 27, nr 5-6 (czerwiec 2003): 207–9. http://dx.doi.org/10.1046/j.1439-0477.2003.03037.x.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
6

Lohse, Ansgar W. "Autoimmune Lebererkrankungen/Autoimmune liver diseases". LaboratoriumsMedizin 27, nr 5/6 (1.01.2003): 207–9. http://dx.doi.org/10.1515/labmed.2003.032.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
7

Ben Salah, Raida, Faten Hadj Kacem, Siddiqa Soomauro, Sarra Chouaib, Faten Frikha, Nedia Charfi, Mohamed Abid i Zouhir Bahloul. "Autoimmune thyroiditis associated with autoimmune diseases". Electronic Journal of General Medicine 19, nr 6 (26.08.2022): em409. http://dx.doi.org/10.29333/ejgm/12399.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
8

Lukešová, Šárka. "Imunology, autoimmune diseases". Medicína pro praxi 13, nr 4 (1.10.2016): 171–74. http://dx.doi.org/10.36290/med.2016.037.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
9

Invernizzi, Pietro, i Ian R. Mackay. "Autoimmune liver diseases". World Journal of Gastroenterology 14, nr 21 (2008): 3290. http://dx.doi.org/10.3748/wjg.14.3290.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
10

Jeong, Dae Chul. "Monogenic Autoimmune Diseases". Journal of Rheumatic Diseases 25, nr 4 (2018): 213. http://dx.doi.org/10.4078/jrd.2018.25.4.213.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.

Rozprawy doktorskie na temat "Autoimmune diseases"

1

Schoonen, Wilma Marieke. "Pharmacoepidemiology of autoimmune diseases". Thesis, London School of Hygiene and Tropical Medicine (University of London), 2007. http://researchonline.lshtm.ac.uk/4646551/.

Pełny tekst źródła
Streszczenie:
The current system in place to study safety of medicines after introduction on the market relies on spontaneous reporting. Adverse events occurring long after initiation or cessation of drug use are likely to be missed by this system. In this thesis we explore methods to identify signals of long-term, unexpected adverse events and methods to evaluate these signals. We utilised data from the UK General Practice Research Database (GPRD), a large primary care database. A systematic review investigating the validity of medical diagnoses recorded in this database illustrated that the GPRD is a powerful tool to study morbidity in primary care. However, intimate knowledge of the complexities of the database is needed to ensure the best use is made of the database. Pre-existing hypotheses of drug-induced systemic lupus erythematosus (SLE) were evaluated using the GPRD. Associations between risk of SLE and exposure to hydralazine, minocycline, and carbamazepine were confirmed using both a matched case-control design and the self controlled case series method. Spontaneous reports of drug-induced SLE recorded in the UK Yellow Card database indicated that symptoms of SLE often resolve after withdrawal of the suspected drug. Using the Smile Plot method to generate signals of drug-induced SLE, we were not able to identify known signals of drug-induced lupus. However, we did identify factors strongly associated with treatment of early symptoms of disease. These findings indicated a high specificity of the Smile Plot method. To improve sensitivity, better hierarchical coding systems for drugs are needed to ensure appropriate grouping. Lastly, we utilised the GPRD to provide an example of a systematically performed drug safety study. In a small subset of data, we generated hypotheses of drug-induced Hashimoto's disease. Associations were subsequently evaluated in a larger subset of data. No drugs were clearly associated with risk of Hashimoto's disease.
Style APA, Harvard, Vancouver, ISO itp.
2

Mustafa, Elwaleed Ibrahim. "Experimental autoimmune sialadenitis : studies of immunopathogenesis, cellular signaling and MHC genetics /". Stockholm, 2001. http://diss.kib.ki.se/2001/91-628-4791-0/.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
3

Madsen, Rasmus Kirkegaard. "Metabolic variation in autoimmune diseases". Doctoral thesis, Umeå universitet, Kemiska institutionen, 2012. http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-59475.

Pełny tekst źródła
Streszczenie:
The human being and other animals contain immensely complex biochemical processes that govern their function on a cellular level. It is estimated that several thousand small molecules (metabolites) are produced by various biochemical pathways in humans. Pathological processes can introduce perturbations in these biochemical pathways which can lead to changes in the amounts of some metabolites.Developments in analytical chemistry have made it possible measure a large number metabolites in a single blood sample, which gives a metabolic profile. In this thesis I have worked on establishing and understanding metabolic profiles from patients with rheumatoid arthritis (RA) and from animal models of the autoimmune diseases diabetes mellitus type 1 (T1D) and RA.Using multivariate statistical methods it is possible to identify differences between metabolic profiles of different groups. As an example we identified differences between patients with RA and healthy volunteers. This can be used to elucidate the biochemical processes that are active in a given pathological condition.Metabolite concentrations are affected by a many other things than the presence or absence of a disease. Both genomic and environmental factors are known to influence metabolic profiles. A main focus of my work has therefore been on finding strategies for ensuring that the results obtained when comparing metabolic profiles were valid and relevant. This strategy has included repetition of experiments and repeated measurement of individuals’ metabolic profiles in order to understand the sources of variation.Finding the most stable and reproducible metabolic effects has allowed us to better understand the biochemical processes seen in the metabolic profiles. This makes it possible to relate the metabolic profile differences to pathological processes and to genes and proteins involved in these.The hope is that metabolic profiling in the future can be an important tool for finding biomarkers useful for disease diagnosis, for identifying new targets for drug design and for mapping functional changes of genomic mutations. This has the potential to revolutionize our understanding of disease pathology and thus improving health care.
Style APA, Harvard, Vancouver, ISO itp.
4

Gambelunghe, Giovanni. "Immunogenetic studies in autoimmune endocrine diseases /". Stockholm, 2003. http://diss.kib.ki.se/2003/91-7349-691-x/.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
5

Graaff, Wiebo Leendert van der. "T cell differentiation in autoimmune diseases". [S.l. : Amsterdam : s.n.] ; Universiteit van Amsterdam [Host], 2003. http://dare.uva.nl/document/70775.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
6

Leeuw, Karina de. "Premature atherosclerosis in systemic autoimmune diseases". [S.l. : [Groningen : s.n.] ; University Library Groningen] [Host], 2008. http://irs.ub.rug.nl/ppn/.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
7

Pliushchyk, D. "Autoimmune diseases. How to prevent them?" Thesis, Sumy State University, 2016. http://essuir.sumdu.edu.ua/handle/123456789/45958.

Pełny tekst źródła
Streszczenie:
An autoimmune disease is a disease in which the immune system mistakenly attacks the body‘s own cells and tissues. Different body parts like digestive system, joints, nerves, blood vessels, red blood cells, connective tissues, skin and endocrine system can be affected. It‘s found that autoimmune diseases and conditions predominantly affect people during the childhood. Autoimmune disease and condition symptoms vary from individual to individual.
Style APA, Harvard, Vancouver, ISO itp.
8

Ning, Shunbin. "Interferon Regulatory Factors and Autoimmune Diseases". Digital Commons @ East Tennessee State University, 2014. https://dc.etsu.edu/etsu-works/6542.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
9

Narayanan, Harish Anandha. "Molecular Understanding of Selected Autoimmune Diseases". Thesis, The University of Arizona, 2010. http://hdl.handle.net/10150/146614.

Pełny tekst źródła
Streszczenie:
Pathogens that affect the immune system, or defects in the immune system contribute to numerous autoimmune diseases. In this paper, we are going to review, analyze and understand recent findings in literature. The papers that are to be reviewed explore the observation of loss of regulatory T cells in individuals with multiple sclerosis, the importance of CD4+ during HIV infection, the role of CCR6 in the immune system and the importance of Pan-DR-Binding Hsp60 self-epitopes in rheumatoid arthritis. So this literary review is limited to understanding major defects in specific parts of the immune system and its role in causing the specific autoimmune disease. The reason for this focus is to highlight the importance of the immune system in the functioning of many processes in our body and more specifically the importance of T cells and its regulators in maintaining the immune system.
Style APA, Harvard, Vancouver, ISO itp.
10

BORTOLOTTI, Daria. "HLA-G MOLECULES IN INFECTION AND AUTOIMMUNE DISEASES". Doctoral thesis, Università degli studi di Ferrara, 2015. http://hdl.handle.net/11392/2389029.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.

Książki na temat "Autoimmune diseases"

1

Khamashta, Munther A., i Manuel Ramos-Casals, red. Autoimmune Diseases. London: Springer London, 2011. http://dx.doi.org/10.1007/978-0-85729-358-9.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
2

Aaseng, Nathan. Autoimmune diseases. New York: F. Watts, 1995.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
3

Aaseng, Nathan. Autoimmune diseases. New York: F. Watts, 1995.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
4

C, Altman Leonard, red. Autoimmune diseases. Philadelphia: Saunders, 1993.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
5

Horváth, Barbara, red. Autoimmune Bullous Diseases. Cham: Springer International Publishing, 2022. http://dx.doi.org/10.1007/978-3-030-91557-5.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
6

Jonkman, Marcel F., red. Autoimmune Bullous Diseases. Cham: Springer International Publishing, 2016. http://dx.doi.org/10.1007/978-3-319-23754-1.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
7

Ohira, Hiromasa, red. Autoimmune Liver Diseases. Tokyo: Springer Japan, 2014. http://dx.doi.org/10.1007/978-4-431-54789-1.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
8

Sami, Naveed, red. Autoimmune Bullous Diseases. Cham: Springer International Publishing, 2016. http://dx.doi.org/10.1007/978-3-319-26728-9.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
9

L, Krawitt Edward, Wiesner Russell H i Nishioka Mikio 1936-, red. Autoimmune liver diseases. Wyd. 2. Amsterdam: Elsevier, 1998.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
10

R, Rose Noel, i Mackay Ian R, red. The Autoimmune diseases. Orlando: Academic Press, 1985.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.

Części książek na temat "Autoimmune diseases"

1

Popper, Helmut, i Bruno Murer. "Autoimmune Diseases". W Essentials of Diagnostic Pathology, 469–93. Cham: Springer International Publishing, 2020. http://dx.doi.org/10.1007/978-3-030-22664-0_28.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
2

Georgiev, Vassil St. "Autoimmune Diseases". W National Institute of Allergy and Infectious Diseases, NIH, 665–74. Totowa, NJ: Humana Press, 2009. http://dx.doi.org/10.1007/978-1-60327-297-1_41.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
3

Sedlacek, H. Harald, i Tarik Möröy. "Autoimmune Diseases". W Immune Reactions, 311–31. Berlin, Heidelberg: Springer Berlin Heidelberg, 1995. http://dx.doi.org/10.1007/978-3-642-79558-9_20.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
4

Bolster, Marcy B. "Autoimmune Diseases". W Challenging Cases in Allergy and Immunology, 265–81. Totowa, NJ: Humana Press, 2009. http://dx.doi.org/10.1007/978-1-60327-443-2_18.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
5

Sroussi, Herve, Joel B. Epstein i Riva Touger-Decker. "Autoimmune Diseases". W Nutrition and Oral Medicine, 277–97. New York, NY: Springer New York, 2014. http://dx.doi.org/10.1007/978-1-60761-490-6_15.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
6

Edwards, N. Lawrence. "Autoimmune Diseases". W Principles of Molecular Medicine, 299–307. Totowa, NJ: Humana Press, 1998. http://dx.doi.org/10.1007/978-1-59259-726-0_34.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
7

Signore, A., i M. Chianelli. "Autoimmune diseases". W Clinical Nuclear Medicine, 139–47. Boston, MA: Springer US, 1998. http://dx.doi.org/10.1007/978-1-4899-3356-0_12.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
8

Bizikova, Petra. "Autoimmune Diseases". W Feline Dermatology, 495–509. Cham: Springer International Publishing, 2020. http://dx.doi.org/10.1007/978-3-030-29836-4_25.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
9

Hughes, Travis, i Amr H. Sawalha. "Autoimmune Diseases". W Epigenetic Aspects of Chronic Diseases, 95–106. London: Springer London, 2011. http://dx.doi.org/10.1007/978-1-84882-644-1_6.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
10

Ishiuji, Yozo, i Alan B. Fleischer. "Autoimmune Diseases". W Pruritus, 189–96. Cham: Springer International Publishing, 2016. http://dx.doi.org/10.1007/978-3-319-33142-3_25.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.

Streszczenia konferencji na temat "Autoimmune diseases"

1

Wang, Julia Y. "GLYCOBIOLOGY AND AUTOIMMUNE RHEUMATIC DISEASES". W XXIst International Carbohydrate Symposium 2002. TheScientificWorld Ltd, 2002. http://dx.doi.org/10.1100/tsw.2002.682.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
2

KCHIR, hela, Dhouha Cherif, Dhilel Issaoui, Maha Mtir, Dhia Kaffel, Faten Limaiem i Nadia Maamouri. "SAT0195 SYSTEMIC DISEASES ASSOCIATED WITH AUTOIMMUNE LIVER DISEASES". W Annual European Congress of Rheumatology, EULAR 2019, Madrid, 12–15 June 2019. BMJ Publishing Group Ltd and European League Against Rheumatism, 2019. http://dx.doi.org/10.1136/annrheumdis-2019-eular.8246.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
3

Brovko, Michael, Michail Kalashnikov, Larisa Akulkina, Victoria Sholomova, Alisa Yanakaewa, Denis Konovalov, Marina Lebedeva, Teona Rosina i Sergey Moiseev. "Lung involvement in autoimmune liver diseases". W ERS International Congress 2019 abstracts. European Respiratory Society, 2019. http://dx.doi.org/10.1183/13993003.congress-2019.pa1374.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
4

LOIOLA, LISIA LAIANE ABREU GOMES, MARINA ISIDÓRIO CRUZ MACEDO, MARIANA MACEDO MILITÃO MENDONÇA, SAMIA ARAUJO DE SOUSA STUDART, MAILZE CAMPOS BEZERRA i REJANE MARIA RODRIGUES DE ABREU. "EVALUATING RELIGIOSITY IN AUTOIMMUNE RHEUMATIC DISEASES". W 36º Congresso Brasileiro de Reumatologia. São Paulo: Editora Blucher, 2019. http://dx.doi.org/10.5151/sbr2019-427.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
5

Ibrahimi, Hajar El. "P358 Extrahepatic autoimmune diseases (EADs) associated with autoimmune hepatitis in adults". W BSG LIVE’24, 17-20 June 2024, ICC Birmingham. BMJ Publishing Group Ltd and British Society of Gastroenterology, 2024. http://dx.doi.org/10.1136/gutjnl-2024-bsg.440.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
6

Casciola-Rosen, Livia, Ami Shah i Antony Rosen. "Abstract IA22: Autoimmune rheumatic diseases and cancer". W Abstracts: Fourth CRI-CIMT-EATI-AACR International Cancer Immunotherapy Conference: Translating Science into Survival; September 30 - October 3, 2018; New York, NY. American Association for Cancer Research, 2019. http://dx.doi.org/10.1158/2326-6074.cricimteatiaacr18-ia22.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
7

Cutolo, M. "SP0045 Oestrogens, immune response and autoimmune diseases". W Annual European Congress of Rheumatology, EULAR 2018, Amsterdam, 13–16 June 2018. BMJ Publishing Group Ltd and European League Against Rheumatism, 2018. http://dx.doi.org/10.1136/annrheumdis-2018-eular.7725.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
8

Bernardino, VR, AC Rodrigues, AC Llado, MA Fernandes, M. Vicente, AC Grilo, A. Panarra i MF Moraes-Fontes. "AB1070 Unravelling autoimmune diseases through nailfold capillaroscopy". W Annual European Congress of Rheumatology, 14–17 June, 2017. BMJ Publishing Group Ltd and European League Against Rheumatism, 2017. http://dx.doi.org/10.1136/annrheumdis-2017-eular.1242.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
9

Tavares, Priscila Garcia Câmara Cabral, Paulo Átila Da Silva Viana, Ester Saraiva Carvalho Feitosa, Vitoria Lotif Santiago, Maria Eduarda Ribeiro Romero, Francisco Tabajara e. Silva Neto, João Gabriel Vale Catunda i Priscila Dourado Evangelista. "ASSOCIATION OF AUTOIMMUNE DISEASES WITH DOWN SYNDROME". W XXXIX Congresso Brasileiro de Reumatologia. Sociedade Brasileiro de Reumatologia, 2022. http://dx.doi.org/10.47660/cbr.2022.2186.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
10

Harrabi, Hejer, Sameh Aissa, Rim Abdelmalek, Badreddine Kilani, Lamia Ammari, Fakher Kanoun, Ahmed Ghoubontini i Hanene Tiouiri Benaissa. "P5.14 Autoimmune diseases in hiv-infected patients". W STI and HIV World Congress Abstracts, July 9–12 2017, Rio de Janeiro, Brazil. BMJ Publishing Group Ltd, 2017. http://dx.doi.org/10.1136/sextrans-2017-053264.630.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.

Raporty organizacyjne na temat "Autoimmune diseases"

1

Senegal Carty, Senegal Carty. How do chemical exposures trigger autoimmune diseases? Experiment, sierpień 2017. http://dx.doi.org/10.18258/9747.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
2

Chen, Cheng-Che, i Chung-Jen Chen. New-Onset Inflammatory Arthritis After Covid-19 Vaccination. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, lipiec 2022. http://dx.doi.org/10.37766/inplasy2022.7.0128.

Pełny tekst źródła
Streszczenie:
Review question / Objective: Investigate the new-onset inflammatory arthritis after Covid-19 vaccination in patients without pre-existing autoimmune nor rheumatic diseases and analyze their clinical patterns. Condition being studied: To help the readers to understand the clinical patterns of new-onset inflammatory arthritis after Covid-19 vaccination in patients without pre-existing autoimmune nor rheumatic diseases. Eligibility criteria: Inclusion criteria: publications of new-onset inflammatory arthritis after Covid-19 vaccination in patients without pre-existing autoimmune nor rheumatic diseases between January 2020 to March 2022. Exclusion criteria: cases with arthritis after SARS-CoV-2 infection and arthritis reactivation in those with underlying or history of arthritis-associated or autoimmune diseases.
Style APA, Harvard, Vancouver, ISO itp.
3

Trofimenko, A., M. Mamus, S. Bedina, E. Mozgovaya i S. Spitsina. PARTICIPATION OF NEUTROPHIL EXTRACELLULAR TRAPS IN AUTOIMMUNE RHEUMATIC DISEASES. DOI CODE, 2021. http://dx.doi.org/10.18411/wco-iof-esceo-2021-509.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
4

Li, Mingqiang, Juan Wan i Zhenhong Xu. The association between Parkinson’s disease and autoimmune diseases: a systematic review and meta-analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, sierpień 2022. http://dx.doi.org/10.37766/inplasy2022.8.0088.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
5

Taneja, Veena. Commensal Gut-Derived Anaerobes as Novel Therapy for Inflammatory Autoimmune Diseases. Fort Belvoir, VA: Defense Technical Information Center, maj 2012. http://dx.doi.org/10.21236/ada561919.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
6

Shahare, Manju Bhaiyalal, Shriyans Reddy Yendreddy, Murshidha Shireen, Bhavit Bansal, Kezia William, Yatindra Kumar, Sauvit Patil i Hridya Ramesh. Exploring the Therapeutic Potential of Phytochemicals in Autoimmune Diseases: A Systematic Literature Review. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, czerwiec 2024. http://dx.doi.org/10.37766/inplasy2024.6.0031.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
7

Rusanova, O. A., O. I. Emelyanova i A. S. Trofimenko. PATTERNS OF PLASMA ANTI-THYROID HORMONE ANTIBODIES IN AUTOIMMUNE RHEUMATIC DISEASES WITH THYROID LESION. DOI CODE, 2021. http://dx.doi.org/10.18411/wco-iof-esceo-2021-422.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
8

Curtis, Jeffrey, Tim Beukelman, Narender Annapureddy, Jim Oates, Megan Clowse, Millie Long, Michael Kappelman i in. Using Research Networks to Compare Medicines for Autoimmune and Inflammatory Diseases – The Comparative Health Outcomes in Immune-mediated diseases CollaborativE (CHOICE) Study. Patient-Centered Outcomes Research Institute (PCORI), październik 2023. http://dx.doi.org/10.25302/10.2023.pprnd.150732163.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
9

Räber, Miro E., Dilara Sahin, Ufuk Karakus i Onur Boyman. A systematic review of interleukin-2-based immunotherapies in clinical trials for cancer and autoimmune diseases. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, listopad 2022. http://dx.doi.org/10.37766/inplasy2022.11.0086.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
10

Yang, Jianguo, ying Sun, peng zhou, Di Zhang, Ziqi Xu, Jiaojiao Cao i Bing Fan. Risk of secondary autoimmune diseases with alemtuzumab treatment for multiple sclerosis: a systematic review and meta-analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, kwiecień 2024. http://dx.doi.org/10.37766/inplasy2024.4.0048.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
Oferujemy zniżki na wszystkie plany premium dla autorów, których prace zostały uwzględnione w tematycznych zestawieniach literatury. Skontaktuj się z nami, aby uzyskać unikalny kod promocyjny!

Do bibliografii